Thursday, December 20, 2012
This week in techniques
Publication and contact
mRNA vaccines to prevent
influenza A infection
Vaccination with a mixture
mRNAs could help prevent influenza A infection. A mixture of
protamine-complexed mRNA was formulated that could be stored for three weeks
without loss of efficacy. In both newborn and aged mice, immunization with a
vaccine containing influenza A virus hemagglutinin and influenza
A virus neuraminidase mRNAs resulted in 100% survival against a
lethal influenza virus challenge and no signs of infection, whereas
immunization with a control antigen led to 0% survival. In pigs, immunization
with a related mRNA vaccine that also contained influenza
A virus nucleoprotein (NP)
mRNA prevented signs of clinical disease following influenza virus challenge,
whereas immunization with a control antigen did not. Next steps include
studying the long-term protection conferred by this vaccine approach.
has mRNA-based vaccines in preclinical development to prevent undisclosed
infections (see Translating mRNA vaccines, page 1).
Published online Dec. 20, 2012
Patented; Sanofi has an exclusive option to
develop vaccines for predefined, undisclosed pathogens; additional
indications available for partnering
Petsch, B. et al. Nat.
Biotechnol.; published online Nov. 25, 2012;
Contact: Lothar Stitz, Friedrich Loeffler Institute,
Greifswald-Insel Riems, Germany
Contact: Karl-Josef Kallen, CureVac GmbH, Tubingen, Germany
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]